Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic interventionEkta Shirbhate, Harish Rajak|Pharmacological Reports|2021Cited by 145
The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatmentEkta Shirbhate, Harish Rajak, Prabodh Chander Sharma et al.|Future Oncology|2020Cited by 21
Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategiesPreeti Patel, Harish Rajak, Ekta Shirbhate et al.|Journal of Biomolecular Structure and Dynamics|2023Cited by 12
Searching for Potential HDAC2 Inhibitors: Structure-activity Relationship Studies on Indole-based Hydroxamic Acids as an Anticancer AgentEkta Shirbhate, Harish Rajak, divya divya divya et al.|Letters in Drug Design & Discovery|2020Cited by 7
Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19Ekta Shirbhate, Harish Rajak, Preeti Patel et al.|Mini-Reviews in Medicinal Chemistry|2020Cited by 2